Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Voyageur Secures First International Sales Contract worth US$1.9 Million (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Fresh Tracks Therapeutics Inc FRTX

Healthcare Biotechnology
Fresh Tracks Therapeutics, Inc. is not engaged in any business activities. The Company is in the process of dissolution.

Recent & Breaking News (PINL:FRTX)

Vical to Present at the 27th Annual ROTH Conference

GlobeNewswire March 5, 2015

Vical Reports Fourth Quarter 2014 Financial Results and Progress in Key Development Programs

GlobeNewswire February 26, 2015

Vical Announces News Release and Conference Call Schedule for Fourth Quarter 2014 Financial Results

GlobeNewswire February 19, 2015

Vical to Present at the Leerink Global Healthcare Conference

GlobeNewswire February 9, 2015

Vical and AnGes Announce Collaboration to Develop Therapy for Ebola Virus Disease

GlobeNewswire January 14, 2015

Vical Completes Enrollment in Its Therapeutic HSV-2 Vaccine Clinical Trial

GlobeNewswire December 11, 2014

Vical to Present at the Piper Jaffray 26th Annual Healthcare Conference

GlobeNewswire November 25, 2014

Vical to Present at the Stifel 2014 Healthcare Conference

GlobeNewswire November 11, 2014

Vical Reports Third Quarter 2014 Financial Results and Progress in Key Development Programs

GlobeNewswire October 30, 2014

Vical Announces News Release and Conference Call Schedule for Third Quarter 2014 Financial Results

GlobeNewswire October 23, 2014

Vical Granted Six U.S. Patents for HSV-2 Vaccines

GlobeNewswire October 8, 2014

Vical to Present at the Rodman and Renshaw 16th Annual Global Investment Conference

GlobeNewswire September 4, 2014

Vical Reports Second Quarter 2014 Financial Results and Progress in Key Development Programs

GlobeNewswire July 31, 2014

Vical Announces News Release and Conference Call Schedule for Second Quarter 2014 Financial Results

GlobeNewswire July 24, 2014

Vical to Present at the JMP Securities Annual Healthcare Conference

GlobeNewswire June 18, 2014

Vical Reports First Quarter 2014 Financial Results and Progress in Key Development Programs

GlobeNewswire May 1, 2014

Vical Announces News Release and Conference Call Schedule for First Quarter 2014 Financial Results

GlobeNewswire April 23, 2014

Vical to Present at the ROTH Capital Partners 26th Annual Growth Stock Conference

GlobeNewswire March 5, 2014

Vical to Present at the 34th Annual Cowen Health Care Conference

GlobeNewswire February 26, 2014

Vical Reports 2013 Financial Results and Progress in Key Development Programs

GlobeNewswire February 12, 2014